AVITA Medical (AVHHL) Cash from Financing Activities (2019 - 2025)

AVITA Medical has reported Cash from Financing Activities for 7 years, with the latest figure at $248000.0 in Q4 2025.

• For the quarter ending Q4 2025, Cash from Financing Activities fell 75.71% year-over-year to $248000.0; the trailing twelve-month figure through Dec 2025 stood at $14.9 million (up 325.77% YoY), and the FY2025 full-year result was $14.9 million, up 325.77% from the prior year.
• Cash from Financing Activities for Q4 2025 stood at $248000.0, down from $13.8 million in the prior quarter.
• The five-year high for Cash from Financing Activities was $64.0 million in Q1 2021, with the low at -$64.0 million in Q2 2022.
• Historically, Cash from Financing Activities has averaged $2.6 million across 5 years, with a median of $579500.0 in 2023.
• Annual changes were most pronounced in 2021 — Cash from Financing Activities jumped 98404.62% — and 2022, when it sank 397.95%.
• AVITA Medical's Cash from Financing Activities stood at $3000.0 in 2021, then surged by 29866.67% to $899000.0 in 2022, then jumped by 4286.21% to $39.4 million in 2023, then slumped by 97.41% to $1.0 million in 2024, then sank by 75.71% to $248000.0 in 2025.
• The last three Cash from Financing Activities figures came in at $248000.0 (Q4 2025), $13.8 million (Q3 2025), and $559000.0 (Q2 2025), per Business Quant data.